BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

  March 26, 2025

   · 

  8 min read
• Press Releases

  Savara Completes Submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

  March 26, 2025

   · 

  6 min read
• Press Releases

  Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference

  March 26, 2025

   · 

  1 min read
• Press Releases

  BioCardia Reports 2024 Business Highlights and Financial Results

  March 26, 2025

   · 

  9 min read
• Press Releases

  Humacyte, Inc. Announces Proposed Public Offering of Common Stock

  March 26, 2025

   · 

  7 min read
• Press Releases

  Nouscom to Present Final Results from Successful Phase Ib/II Trial of NOUS-209 in People Living with Lynch Syndrome, Demonstrating Powerful Potential to Intercept Cancer in its Earliest Stages of Development

  March 26, 2025

   · 

  6 min read
• Press Releases

  Arcus Biosciences Announces New Employment Inducement Grants - March 25, 2025

  March 26, 2025

   · 

  1 min read
• Press Releases

  Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

  March 26, 2025

   · 

  1 min read
• Press Releases

  Blujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older

  March 26, 2025

   · 

  11 min read
• Press Releases

  Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025

  March 26, 2025

   · 

  7 min read